Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 1, 2015
0Patent Application Number
145058660
Date Filed
October 3, 2014
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.